Arrowhead to Present at Deutsche Bank 39th Annual Health Care Conference

Business Wire


Arrowhead Research Corporation (ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that Bruce Given, M.D., Chief Operating Officer, will present at the Deutsche Bank 39th Annual Health Care Conference on Thursday, May 8, 2014 at 12:50 p.m. EDT at the InterContinental hotel in Boston.

A live webcast of the presentation can be accessed by visiting the company’s website, A replay will also be archived on the website.

About Arrowhead Research Corporation

Arrowhead Research Corporation is a biopharmaceutical company developing targeted RNAi therapeutics. The company is leveraging its proprietary drug delivery technologies to develop targeted drugs based on the RNA interference mechanism that efficiently silences disease-causing genes. Arrowhead technologies also enable partners to create peptide-drug conjugates that specifically home to cell types of interest while sparing off-target tissues. Arrowhead’s pipeline includes clinical programs in chronic hepatitis B virus and partner-based programs in obesity and oncology.

For more information please visit, or follow us on Twitter @ArrowRes. To be added to the Company's email list to receive news directly, please send an email to

Arrowhead Research Corporation
Vince Anzalone, CFA
Investor Relations:
The Trout Group
Lauren Glaser
Russo Partners
Martina Schwarzkopf, Ph.D.

View Comments (0)